Rocket Lab's third-quarter 2026 results arrived at a pivotal moment for the end-to-end space company. The quarter marked its sixth consecutive record-revenue period, reinforcing the demand narrative that has supported its rapid expansion across launch and space systems. At the same time, the report highlighted the costs of scaling: elevated spending on the Neutron medium-lift rocket and acquisition-related expenses widened losses even as the top line surged. In my view, this report mattered because it tested whether Rocket Lab can convert explosive revenue and backlog growth into a clearer path toward profitability, while the Neutron timeline shift added fresh questions about execution.
Rocket Lab posted third-quarter revenue of $267.8 million, a 73% year-over-year increase that topped the consensus estimate of roughly $258 million. Space Systems revenue climbed to $214.8 million, up 88% year over year, while Launch Services revenue rose to $53.1 million, up about 30%. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
On the bottom line, the company reported a GAAP net loss of $79.7 million, or $0.12 per share, compared with a net loss of $18.3 million, or $0.03 per share, a year earlier. The loss per share missed the consensus estimate of about $0.07, partly reflecting a $27.3 million loss on debt extinguishment and elevated research and development spending tied to the Neutron program.
GAAP gross margin came in at 33.6%, with non-GAAP gross margin at 38.4%. Adjusted EBITDA was a loss of $18 million. Notably, GAAP operating cash flow turned positive at $7.2 million. Backlog surged to a record $3.57 billion, and the company reported 117 launches in its launch backlog, including 16 Neutron missions.
For the fourth quarter of 2026, management guided revenue of $270 million to $290 million, an adjusted EBITDA loss of $14 million to $20 million, and non-GAAP gross margin of 39% to 41%.
Shares of Rocket Lab slipped in after-hours trading following the report, with the stock down roughly 3.8% to 6.6% in early reaction. The mixed response reflected a tension in the results: revenue, backlog, and fourth-quarter revenue guidance all exceeded expectations, but the wider-than-expected loss and the Neutron delay tempered enthusiasm. From what I see, investors appeared to weigh the strength of demand against the rising cost structure and the postponed timeline for Neutron's debut. The stock's reaction suggests the market is increasingly focused on the company's ability to narrow losses and reach sustained profitability, rather than on revenue growth alone.
Looking ahead, several factors will shape investor sentiment around Rocket Lab. The Neutron timeline is the most closely watched variable. Management now targets the rocket's first launch for no earlier than 2027, and the company has indicated that adjusted EBITDA could turn positive within roughly six months of a successful first flight. Any further schedule movement will likely drive the stock.
Pricing power is another key theme. Rocket Lab raised Neutron's base price to $70 million for several missions, up from $55 million, citing tightening industry launch capacity. Management also signaled potential price increases across Electron and HASTE, which could support margins as launch volume scales.
Finally, the pending acquisition of satellite communications company Iridium is worth monitoring. The transaction, which has received shareholder approval but has not yet closed, could reshape Rocket Lab's cash flow and communications capabilities. Together, execution on Neutron, pricing trends, and the Iridium integration will be the central factors to watch in the quarters ahead. I’m watching this closely as the next few updates could clarify the path forward.
One tool I rely on for deeper analysis is Tickeron’s AI Screener. It helps filter stocks and ETFs using technical patterns, fundamentals, trends, volatility, and AI-driven signals, allowing users to scan thousands of names with customizable criteria like industry, market cap, and performance metrics. This streamlines identifying trade ideas and comparing opportunities more efficiently than manual methods, which has been useful when evaluating names like Rocket Lab alongside peers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The RSI Indicator for RKLB moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In 30 of the 33 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 65 cases where RKLB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on RKLB as a result. In 77 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.
The Moving Average Convergence Divergence (MACD) for RKLB just turned positive on November 09, 2026. Looking at past instances where RKLB's MACD turned positive, the stock continued to rise in 40 of 44 cases over the following month. The odds of a continued upward trend are 90%.
Following a +27.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 265 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
RKLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
RKLB moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RKLB crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for RKLB entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.717) is normal, around the industry mean (5.050). RKLB's P/E Ratio (-196.556) is considerably lower than the industry average of (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (48.309) is also within normal values, averaging (18.367).
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RKLB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense